69256-17-3

FMAU D-FMAU Ara-2'-F-2'-dT 2'-Fluoro-5-methylarabinosyluracil FMAU, 2'-Fluoro-5-methylarabinosyluracil 2’-Deoxy-2’-fluoro-5-methyl-β-D-arabinouridine 2'-Fluoro-5-methyl-1--D-arabinofuranosyluracil 2'-Fluoro-5-methyl-1-β-D-arabinofuranosyluracil 1-(2-Fluoro-2-deoxy-β-D-arabinofuranosyl)thymine 2'-Deoxy-2'-fluoro-5-Methyl-beta-D-arabinouridine 2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil 2’-Deoxy-2’-fluoro-5-methyl-beta-D-arabinouridine, FMAU 1-(2-Deoxy-2-fluoro-b-D-arabinofuranosyl)-5-Methyluracil 5-Methyl-1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)uracil 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyluracil 1-(2-Deoxy-2-fluoro-.β.-D-arabinofuranosyl)-5-methyluracil 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-methyl- 2’-Deoxy-2’-fluoro-5-methyl-beta-D-arabinouridine, FMAU, HBV drug Metabolite of FIAC GL100674 1-[(2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione 1-((2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione